VTD-PACE regimen

WikiDoc Resources for VTD-PACE regimen
Articles
Most recent articles on VTD-PACE regimen Most cited articles on VTD-PACE regimen Review articles on VTD-PACE regimen Articles on VTD-PACE regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on VTD-PACE regimen Images of VTD-PACE regimen Photos of VTD-PACE regimen Podcasts & MP3s on VTD-PACE regimen Videos on VTD-PACE regimen
Evidence Based Medicine
Cochrane Collaboration on VTD-PACE regimen Bandolier on VTD-PACE regimen TRIP on VTD-PACE regimen
Clinical Trials
Ongoing Trials on VTD-PACE regimen at Clinical Trials.gov Trial results on VTD-PACE regimen Clinical Trials on VTD-PACE regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on VTD-PACE regimen NICE Guidance on VTD-PACE regimen NHS PRODIGY Guidance FDA on VTD-PACE regimen CDC on VTD-PACE regimen
Books
Books on VTD-PACE regimen
News
VTD-PACE regimen in the news Be alerted to news on VTD-PACE regimen News trends on VTD-PACE regimen
Commentary
Blogs on VTD-PACE regimen
Definitions
Definitions of VTD-PACE regimen
Patient Resources / Community
Patient resources on VTD-PACE regimen Discussion groups on VTD-PACE regimen Patient Handouts on VTD-PACE regimen Directions to Hospitals Treating VTD-PACE regimen Risk calculators and risk factors for VTD-PACE regimen
Healthcare Provider Resources
Symptoms of VTD-PACE regimen Causes & Risk Factors for VTD-PACE regimen Diagnostic studies for VTD-PACE regimen Treatment of VTD-PACE regimen
Continuing Medical Education (CME)
CME Programs on VTD-PACE regimen
International
VTD-PACE regimen en Espanol VTD-PACE regimen en Francais
Business
VTD-PACE regimen in the Marketplace Patents on VTD-PACE regimen
Experimental / Informatics
List of terms related to VTD-PACE regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: Velcade-thalidomide-dexamethasone-Platinum-Adriamycin-cyclophosphamide-etoposide regimen

Overview

VTD-PACE regimen refers to a regimen consisting of bortezomib (Velcade), thalidomide, dexamethasone, Platinum (cisplatin), Adriamycin (doxorubicin), cyclophosphamide, and etoposide used to treat multiple myeloma.

Regimen

VBortezomib (Velcade)

TThalidomide

DDexamethasone

PPlatinum (cisplatin)

AAdriamycin (doxorubicin)

CCyclophosphamide

EEtoposide

Indications

• Multiple myeloma